For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Syntonix Pharmaceuticals, Inc.

USPTO Granted Patents = 14

EPO Patents = 1

Forward Citations = 836

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Robert T Peters (10 out of 61 patents)

Alan J Bitonti (10 out of 43 patents)

Adam Robert Mezo (7 out of 24 patents)

4. Daniel S Rivera (5 out of 11 patents)

5. Susan C Low (5 out of 21 patents)

6. Kevin McDonnell (3 out of 28 patents)

7. James Stattel (3 out of 3 patents)

8. Christopher TenHoor (2 out of 14 patents)

9. Robert Charles Ladner (2 out of 107 patents)

10. Jennifer A Dumont (2 out of 18 patents)

11. Aaron Sato (2 out of 77 patents)

12. Arumugam Muruganandam (2 out of 10 patents)

13. Liming Liu (2 out of 3 patents)

14. Clive R Wood (2 out of 37 patents)

15. Malini Viswanathan (1 out of 20 patents)

14 patents: Sort by Forward Citations

1. 8815246 - Fc receptor binding proteins (2014-08-26),

2. 8449884 - Clotting factor-fc chimeric proteins to treat hemophilia (2013-05-28),

3. 8329182 - Immunoglobulin chimeric monomer-dimer hybrids (2012-12-11),

4. 8293707 - Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity (2012-10-23),

5. 8273351 - Fc receptor binding proteins (2012-09-25),

6. 8101186 - Peptides that block the binding of IgG to FcRn (2012-01-24),

7. 8021880 - PC5 as a factor IX propeptide processing enzyme (2011-09-20),

8. 7862820 - Immunoglobulin chimeric monomer-dimer hybrids (2011-01-04),

9. 7820162 - Methods for chemically synthesizing immunoglobulin chimeric proteins (2010-10-26),

10. 7795400 - PC5 as a factor IX propeptide processing enzyme (2010-09-14),

11. 7566565 - PC5 as a factor IX propeptide processing enzyme (2009-07-28),

12. 7404956 - Immunoglobulin chimeric monomer-dimer hybrids (2008-07-29),

13. 7381408 - Methods for chemically synthesizing immunoglobulin chimeric proteins (2008-06-03),

14. 7348004 - Immunoglobulin chimeric monomer-dimer hybrids (2008-03-25),

Syntonix Pharmaceuticals, Inc. is a biotechnology company focusing on developing innovative therapeutics for autoimmune diseases and cancer. Our team of experts is dedicated to utilizing advanced technologies to discover and bring breakthrough treatments to patients. With a strong commitment to scientific excellence, our goal is to improve patient outcomes and enhance their quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#86 in Waltham, MA

#1,315 in Massachusetts

#21,641 in US

#40,933 in the World

Waltham, MA, United States of America

Syntonix Pharmaceuticals, Inc.

Forward Citations = 836

17 inventors:

Robert T Peters (10 out of 61 patents)

Alan J Bitonti (10 out of 43 patents)

Adam Robert Mezo (7 out of 24 patents)

4. Daniel S Rivera (5 out of 11 patents)

5. Susan C Low (5 out of 21 patents)

Please report any incorrect information to support@idiyas.com

Loading…